DELFRANA Trademark

Trademark Overview

On Thursday, August 7, 2014, a trademark application was filed for DELFRANA with the United States Patent and Trademark Office. The USPTO has given the DELFRANA trademark a serial number of 79154251. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, July 14, 2021. This trademark is owned by NOVARTIS AG. The DELFRANA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-inf...
delfrana

General Information

Serial Number79154251
Word MarkDELFRANA
Filing DateThursday, August 7, 2014
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, July 14, 2021
Registration Number4766534
Registration DateTuesday, July 7, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 21, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics
Translation of Words in MarkThe English translation of "DEL FRANA" in the mark is "OF THE LANDSLIDE".

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateWednesday, July 14, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Tuesday, September 20, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Sunday, December 12, 2021REFUSAL PROCESSED BY IB
Saturday, July 31, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Saturday, July 31, 2021DEATH OF INTERNATIONAL REGISTRATION
Tuesday, July 7, 2020COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, November 20, 2015FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, November 2, 2015FINAL DISPOSITION NOTICE SENT TO IB
Monday, November 2, 2015FINAL DISPOSITION PROCESSED
Wednesday, October 7, 2015FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 7, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, April 21, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 21, 2015PUBLISHED FOR OPPOSITION
Friday, April 17, 2015NOTIFICATION PROCESSED BY IB
Wednesday, April 1, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 1, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 1, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 13, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 9, 2015ASSIGNED TO LIE
Wednesday, February 18, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 17, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 17, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 17, 2015TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, February 13, 2015NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, February 13, 2015FINAL REFUSAL E-MAILED
Friday, February 13, 2015FINAL REFUSAL WRITTEN
Thursday, February 12, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 12, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 12, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 17, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 17, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 5, 2014REFUSAL PROCESSED BY IB
Tuesday, November 18, 2014APPLICATION FILING RECEIPT MAILED
Monday, November 17, 2014NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, November 17, 2014REFUSAL PROCESSED BY MPU
Friday, November 14, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, November 13, 2014NON-FINAL ACTION WRITTEN
Wednesday, November 12, 2014ASSIGNED TO EXAMINER
Wednesday, November 12, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, November 7, 2014LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, November 6, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

delfrana system disorders preparations pharmaceutical prevention treatment diseases cancer tumors ophthalmology